Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
TAS2R8 functions as a bitter taste receptor, detecting bitter compounds in food to help avoid ingestion of potentially toxic substances. It is a G-protein-coupled receptor (GPCR) expressed in subsets of taste receptor cells in the tongue and palate, and its activation leads to a signal transduction cascade involving α-gustducin, PLCβ2, IP3, calcium release, and ultimately, neurotransmitter release for the perception of bitterness.
Activation of G-proteins (α-gustducin), stimulation of phospholipase C beta 2 (PLCβ2), IP3 production and intracellular calcium release, activation of TRPM5 channels, cell depolarization, and neurotransmitter ATP release via CALHM channels.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Taste receptor type 2 member 8 (TAS2R8).